Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GEMP

Gemphire Therapeutics (GEMP)

Gemphire Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GEMP
DateTimeSourceHeadlineSymbolCompany
01/17/20186:30AMGlobeNewswire Inc.Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) PatientsNASDAQ:GEMPGemphire Therapeutics Inc
12/21/20176:00AMGlobeNewswire Inc.Gemphire Therapeutics Announces Initiation of its First NASH Proof-of-Concept Clinical Trial and its Differentiated NASH Prog...NASDAQ:GEMPGemphire Therapeutics Inc
11/22/20176:00AMGlobeNewswire Inc.Gemphire to Present at the Piper Jaffray and LD Micro Investor ConferencesNASDAQ:GEMPGemphire Therapeutics Inc
11/13/20171:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
11/13/20171:30PMGlobeNewswire Inc.Gemphire Therapeutics Presents Data at American Heart Association (AHA) Scientific Sessions Showing that Gemcabene Significan...NASDAQ:GEMPGemphire Therapeutics Inc
11/13/20179:06AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
10/23/20178:00AMGlobeNewswire Inc.Positive Gemcabene Results in Proof-of-Concept Preclinical NASH Study Presented at The Liver MeetingĀ® 2017NASDAQ:GEMPGemphire Therapeutics Inc
09/25/20179:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
09/25/20179:00AMGlobeNewswire Inc.Gemphire to Present New COBALT-1 Clinical Data at the 2017 FH Global SummitNASDAQ:GEMPGemphire Therapeutics Inc
09/19/20174:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
09/19/20174:01PMGlobeNewswire Inc.Gemphire Announces Plans to Advance Gemcabene into Phase 3 Clinical DevelopmentNASDAQ:GEMPGemphire Therapeutics Inc
09/18/20178:00AMGlobeNewswire Inc.Gemphire to Present at Cantor Fitzgerald Global Healthcare Conference on September 26 in New YorkNASDAQ:GEMPGemphire Therapeutics Inc
09/14/20174:36PMGlobeNewswire Inc.Gemphire to Host Investor Conference Call to Discuss Future Development Plans for GemcabeneNASDAQ:GEMPGemphire Therapeutics Inc
09/13/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
09/11/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
09/01/20174:52PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GEMPGemphire Therapeutics Inc
09/01/20174:49PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GEMPGemphire Therapeutics Inc
08/16/20174:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
08/15/20174:24PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GEMPGemphire Therapeutics Inc
08/14/20179:21AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
08/14/20179:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
08/14/20178:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
08/14/20176:00AMGlobeNewswire Inc.Gemphire Announces Second Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
08/11/20174:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
08/07/201711:57AMGlobeNewswire Inc.Gemphire Therapeutics Inc. (Nasdaq: GEMP) to Ring The Nasdaq Stock Market Closing BellNASDAQ:GEMPGemphire Therapeutics Inc
08/07/201710:00AMGlobeNewswire Inc.Gemphire to Present at the Canaccord Genuity Growth Conference 2017NASDAQ:GEMPGemphire Therapeutics Inc
08/07/20178:08AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
08/07/20178:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
08/07/20176:00AMGlobeNewswire Inc.Gemphire Announces Top-Line Data from ROYAL-1 Phase 2b Clinical Trial in Hypercholesterolemic PatientsNASDAQ:GEMPGemphire Therapeutics Inc
08/02/20174:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GEMP